1. Home
  2. DCI vs RGEN Comparison

DCI vs RGEN Comparison

Compare DCI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCI
  • RGEN
  • Stock Information
  • Founded
  • DCI 1915
  • RGEN 1981
  • Country
  • DCI United States
  • RGEN United States
  • Employees
  • DCI N/A
  • RGEN N/A
  • Industry
  • DCI Pollution Control Equipment
  • RGEN Medical/Dental Instruments
  • Sector
  • DCI Industrials
  • RGEN Health Care
  • Exchange
  • DCI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • DCI 7.9B
  • RGEN 8.0B
  • IPO Year
  • DCI 1987
  • RGEN N/A
  • Fundamental
  • Price
  • DCI $70.96
  • RGEN $130.52
  • Analyst Decision
  • DCI Hold
  • RGEN Buy
  • Analyst Count
  • DCI 3
  • RGEN 11
  • Target Price
  • DCI $70.00
  • RGEN $169.33
  • AVG Volume (30 Days)
  • DCI 530.2K
  • RGEN 684.9K
  • Earning Date
  • DCI 08-27-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • DCI 1.71%
  • RGEN N/A
  • EPS Growth
  • DCI N/A
  • RGEN N/A
  • EPS
  • DCI 2.99
  • RGEN N/A
  • Revenue
  • DCI $3,645,600,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • DCI $3.11
  • RGEN $13.93
  • Revenue Next Year
  • DCI $3.41
  • RGEN $14.35
  • P/E Ratio
  • DCI $23.45
  • RGEN N/A
  • Revenue Growth
  • DCI 3.26
  • RGEN 4.88
  • 52 Week Low
  • DCI $57.45
  • RGEN $102.97
  • 52 Week High
  • DCI $78.95
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • DCI 58.83
  • RGEN 58.30
  • Support Level
  • DCI $69.94
  • RGEN $123.34
  • Resistance Level
  • DCI $71.56
  • RGEN $129.11
  • Average True Range (ATR)
  • DCI 0.96
  • RGEN 4.19
  • MACD
  • DCI 0.11
  • RGEN 0.82
  • Stochastic Oscillator
  • DCI 84.42
  • RGEN 94.16

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: